FR2388804A1 - Nouveaux derives des acides oxazole- et thiazole-alkanoiques et leur application en therapeutique humaine - Google Patents

Nouveaux derives des acides oxazole- et thiazole-alkanoiques et leur application en therapeutique humaine

Info

Publication number
FR2388804A1
FR2388804A1 FR7808344A FR7808344A FR2388804A1 FR 2388804 A1 FR2388804 A1 FR 2388804A1 FR 7808344 A FR7808344 A FR 7808344A FR 7808344 A FR7808344 A FR 7808344A FR 2388804 A1 FR2388804 A1 FR 2388804A1
Authority
FR
France
Prior art keywords
oxazole
thiazole
application
alkanoic acids
new derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7808344A
Other languages
English (en)
Inventor
Tsutomu Yamanaka
Hiroshi Yasuda
Kunio Osuga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Welfide Corp
Original Assignee
Welfide Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Welfide Corp filed Critical Welfide Corp
Publication of FR2388804A1 publication Critical patent/FR2388804A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/46—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/36—One oxygen atom
    • C07D263/42—One oxygen atom attached in position 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Nouveaux composés de la famille des acides oxazole-alkanoïques et thiazole-alkanoïques, caractérisés par la formule génerale :
FR7808344A 1977-03-25 1978-03-22 Nouveaux derives des acides oxazole- et thiazole-alkanoiques et leur application en therapeutique humaine Withdrawn FR2388804A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3346977A JPS53119866A (en) 1977-03-25 1977-03-25 5-aryloxy-oxazoleakanoic acid derivatives and their preparation

Publications (1)

Publication Number Publication Date
FR2388804A1 true FR2388804A1 (fr) 1978-11-24

Family

ID=12387395

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7808344A Withdrawn FR2388804A1 (fr) 1977-03-25 1978-03-22 Nouveaux derives des acides oxazole- et thiazole-alkanoiques et leur application en therapeutique humaine

Country Status (7)

Country Link
US (1) US4175130A (fr)
JP (1) JPS53119866A (fr)
BE (1) BE865332A (fr)
DE (1) DE2812353A1 (fr)
FR (1) FR2388804A1 (fr)
GB (1) GB1575190A (fr)
SE (1) SE7803363L (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5677268A (en) * 1979-11-28 1981-06-25 Yoshitomi Pharmaceut Ind Ltd Oxazoleacetic acid derivative
ATE144142T1 (de) * 1991-01-10 1996-11-15 Transcend Therapeutics Inc Verwendung von thiazolidin-4-carboxylatderivaten zur behandlung von lungenerkrankungen
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
US5866595A (en) * 1991-09-26 1999-02-02 The Regents Of The University Of California Calcium antagonists for treatment of vascular restenosis
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5306724A (en) * 1992-08-17 1994-04-26 Clintec Nutrition Company Method for preventing and treating atherosclerosis
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
US20040248950A1 (en) * 2001-08-24 2004-12-09 Natsuki Ishizuka Apo ai expression accelerating agent
GB0323348D0 (en) * 2003-10-06 2003-11-05 Cambridge Theranostics Ltd Methods and means for modulating lipid metabolism

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2263772A1 (fr) * 1974-03-13 1975-10-10 Yoshitomi Pharmaceutical

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2500142A (en) * 1947-04-24 1950-03-07 Gen Aniline & Film Corp Thio-ether substituted thiazoles and selenazoles and process of preparing the same
US4053478A (en) * 1974-03-13 1977-10-11 Yoshitomi Pharmaceutical Industries, Ltd. 2,5-di-substituted 4-oxazolealkanoic acids and esters
JPS5217467A (en) 1975-07-25 1977-02-09 Yoshitomi Pharmaceut Ind Ltd Process for preparation of 5-alkoxy-2- oxazoleacetate or propionate de rivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2263772A1 (fr) * 1974-03-13 1975-10-10 Yoshitomi Pharmaceutical

Also Published As

Publication number Publication date
SE7803363L (sv) 1978-09-26
JPS53119866A (en) 1978-10-19
GB1575190A (en) 1980-09-17
DE2812353A1 (de) 1978-09-28
US4175130A (en) 1979-11-20
BE865332A (fr) 1978-09-25

Similar Documents

Publication Publication Date Title
FR2392016A1 (fr) Derives de mevalonolactone, leur procede de preparation et leur application therapeutique
FR2417500A1 (fr) Derives d'amino-acides cycliques dehydrogenes et leur utilisation therapeutique
FR2406641A1 (fr) 2,6-diaminonebularines et leur application therapeutique
FR2364219A1 (fr) Derives de thiazolidine, leur procede de preparation et leur application en therapeutique
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
FR2400500A1 (fr) Derives d'acides cycloalcoylidenemethylphenylacetiques, leur procede de preparation et leur application en therapeutique
FR2380285A1 (fr) Nouveaux derives insatures d'acides 7-acylamido-3-cephem-4-carboxyliques, utiles notamment comme agents antibacteriens, et leur procede de preparation
FR2381753A1 (fr) Nouveaux derives de la pyrrolidine, leur procede de preparation et leur application en therapeutique
FR2384811A1 (fr) Derives de la neocarzinostatine, leur application therapeutique et leur procede de preparation
FR2388804A1 (fr) Nouveaux derives des acides oxazole- et thiazole-alkanoiques et leur application en therapeutique humaine
FR2387214A1 (fr) Derives du p-aminomethyl benzene-sulfonamide, leur procede de preparation et leur application therapeutique
FR2401907A1 (fr) Derives de 2-hydroxy-benzamide et leur application comme fongicides
FR2401161A1 (fr) Nouveaux derives de purine, leur preparation et leur application au traitement de la coccidiose
FR2397399A1 (fr) Nouveaux derives inosadiamine et leur application comme agents antimitotiques
FR2395998A1 (fr) Nouveaux derives de la thiazolidine et leur application dans le traitement de l'hypertension
FR2358401A1 (fr) Nouveaux derives d'oxadiazine, leur procede de preparation et leur application comme insecticides
FR2435466A1 (fr) Derives de l'hydroquinone et leur procede de preparation
FR2399406A1 (fr) Derives de perhydronaphtalenepentol et leur utilisation therapeutique
FR2368489A1 (fr) Derives de la clavuline, leur procede de preparation et leur application en therapeutique
FR2400525A1 (fr) Nouveaux derives de 3-amino-17a-aza-d-homoandrostane, leur procede de preparation et les compositions pharmaceutiques les contenant
FR2363541A1 (fr) Acyloxy-n,n' diacylmalonamides et leur mode de preparation
FR2446282A1 (fr) Phenylthiophenylpiperidines, leur preparation et leurs applications therapeutiques
FR2381038A2 (fr) Nouveaux derives de la carbamoyloxymethyl-5 oxazolidinone-2 leur procede de preparation et leur application en therapeutique
FR2429212A1 (fr) Derives de phenylpiperazine et leur application en therapeutique
FR2428636A1 (fr) Nouveaux acides dihydrobenzofurannylacetiques a-substitues, et leur preparation

Legal Events

Date Code Title Description
ST Notification of lapse